Discontinuation report SANDOZ QUETIAPINE
Report ID | 118589 |
Drug Identification Number | 02314002 |
Brand name | SANDOZ QUETIAPINE |
Common or Proper name | SANDOZ QUETIAPINE |
Company Name | SANDOZ CANADA INCORPORATED |
Market Status | CANCELLED POST MARKET |
Active Ingredient(s) | QUETIAPINE |
Strength(s) | 100MG |
Dosage form(s) | TABLET |
Route of administration | ORAL ORAL |
Packaging size | 500 FCT BO |
ATC code | N05AH |
ATC description | ANTIPSYCHOTICS |
Reason for discontinuation | Manufacturing issues |
Anticipated discontinuation date | |
Actual discontinuation date | 2020-06-17 |
Remaining supply date | 2020-06-17 |
Discontinuation status | Discontinued |
Discontinuation decision reversal | No |
Information on remaining supply | |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 110 RUE DE LAUZON BOUCHERVILLE, QUEBEC CANADA J4B 1E6 |
Company contact information | 1 800-361-3062 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v2 | 2020-06-22 | French | Compare |
v1 | 2020-06-22 | English | Compare |
Showing 1 to 2 of 2